Onconetix share price logo

Onconetix

NASDAQ: ONCO

$0.56

-0.03

(-5.66%)

as on

Onconetix Stock Performance

as on October 14, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.54
    $0.58
    downward going graph

    3.05%

    Downside

    4.13%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.56
    $200.00
    downward going graph

    -0.54%

    Downside

    35806.64%

    Upside

    downward going graph

Onconetix share price movements today

Previous Close
$0.59
Open
$0.56
Volume
945.5K
Market Cap
$3.2M
Day's Low - High
$0.54 - $0.58
52 Week Low - High
$0.56 - $200.00

Onconetix Historical Returns

1 Month Return
-21.95 %
3 Month Return
-31.51 %
1 Year Return
-99.68 %
3 Year Return
0 %
5 Year Return
0 %

Onconetix Stock Fundamentals & Key Indicators

Check Onconetix market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.2M

EPS (TTM)

-8.7357

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.07

Industry PE ratio

-2.34

PEG Ratio

-0.00

EBITDA

-9.9M

Revenue (TTM)

645.8K

Profit Margin

80.40%

Return On Equity TTM

-91.95%

Onconetix vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Onconetix with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Onconetix image
Onconetix
Hold$3.2MNA-0.0780.40%0.00%
Moderna image
Moderna
Neutral$89.8B-33.52%-28.20-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$129.3B179.59%29.4586.04%0.00%
Regeneron image
Regeneron
Buy$76.9B39.42%17.8384.86%0.50%

Stock Returns calculator for Onconetix Stock including INR - Dollar returns

The Onconetix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Onconetix investment value today

Current value as on today

₹325

Returns

-₹99,675

(-99.67%)

Returns from Onconetix Stock

-₹99,697 (-99.7%)

Dollar Impact

₹23 (+0.02%)

Analyst Recommendation on Onconetix Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Onconetix. Average target price of $9

Onconetix Share Price Target

Get share price movements and forecasts by analysts on Onconetix.

What analysts predicted

93.81%UPSIDE

Target Price

$9

Current Price

$0.557

Analyzed by

6 Analysts

Target

$9.00

Onconetix target price $9, a slight upside of 93.81% compared to current price of $0.557. According to 6 analysts rating.

Indian Investors' Interest in Onconetix Stock

Investment in Onconetix Shares on INDmoney has grown by 726.31% in the last 30 days, indicating increased investment activity.

Time period: to

Change:726.31% versus previous 30 day period

Search interest for Onconetix Stock has increased by 494% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:494% versus previous 30 day period

Onconetix Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-11
-13
-2
-29
-1
-1
-2
-1
-2
-2
EBITDA
-10
-13
-3
-29
-8
-2
-8
5
-4
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-14
-3
-30
-8
-2
-8
5
-4
-2
Income Tax Expense
0
0
0
0
-
-
-
0
-
-
Net Income
-11
-14
-3
-29
-8
-2
-8
5
-4
-2
Net Profit Margin
26.98%
14.29%
25.91%
92.70%
45.10%
66.20%
88.55%
81.58%
-7.71%
25.13%

Onconetix Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
2
0
Gross Profit
0
0
0
0
-1
1
0
Operating Income
0
-1
-3
-13
-36
-56
-6
EBITDA
0
-1
-3
-13
-36
-57
-13
Interest Expense
-
-
-
-
0
1
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
0
-1
-3
-13
-37
-59
-14
Income Tax Expense
-
-
-
-
0
-1
0
Net Income
0
-1
-3
-13
-37
-58
-14
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-1927.93%
41.80%
77.62%

Onconetix Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-14
-3
-29
-8
-2
-8
5
-4
-2
Operating Cash Flow
-5
-3
-1
0
-1
-1
-3
-3
-2
-1
Investing Cash Flow
0
0
0
0
-
-
-
-
-
-
Financing Cash Flow
5
0
0
1
2
0
4
6
0
4
Change in Cash
0
-3
0
0
0
-1
0
4
-1
2

Onconetix Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-1
-3
-13
-37
-58
-14
Operating Cash Flow
0
-1
-2
-8
-13
-10
-9
Investing Cash Flow
0
0
0
0
-8
0
-
Financing Cash Flow
6
-
0
32
1
6
14
Change in Cash
6
-1
-2
23
-21
-3
4

Global Institutional Holdings in Onconetix

Check out the Institutions with significant holdings in Onconetix.

Funds
Holdings
Hollencrest Securities, LLC
0.00%
Geode Capital Management, LLC
0.10%
Citigroup Inc
0.01%
DRW Securities, LLC
0.00%
Danske Bank A/S.
0.00%
See all

Onconetix News & Key Events

  • img

    Today's Timeline - 14 September

    Mon, 08:47 PM

    -

    Onconetix provides $5 million bridge financing to Realbotix, supporting growth and pending acquisition plans.

Insights on Onconetix

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 117.4% return, outperforming this stock by 73.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 699.3% return, outperforming this stock by 799.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, ONCO stock has moved down by -92.6%

About Onconetix

Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The company's product lineup includes Entadfi, an FDA-cleared, once-daily oral medication. This prescription drug combines finasteride and tadalafil to manage benign prostatic hyperplasia (BPH). In its development pipeline, Onconetix is advancing a Streptococcus pneumoniae vaccine candidate, designed to prevent infectious middle ear infections in children and pneumonia in the elderly. Additionally, they are working on a universal influenza vaccine intended to provide comprehensive protection against all aggressive strains of the flu virus. Furthermore, Onconetix holds a license for an advanced norovirus S&P nanoparticle virus-like particle (VLP) vaccine platform from Cincinnati Children's. This adaptable platform is being leveraged to create vaccines for various infectious diseases, such as Marburg and monkeypox, among others. Established in 2018, the company was previously known as Blue Water Biotech, Inc., before changing its name to Onconetix, Inc. in December 2023. Its corporate headquarters are located in Cincinnati, Ohio.
OrganisationOnconetix
Headquarters201 East Fifth Street, Cincinnati, OH, 45202, US
IndustryBiotechnology
CEODavid Allan White

Key Management of Onconetix

Name

Title

Dr. Ali I. Fattom Ph.D.

Head of Science & Discovery

Dr. Jay Newmark M.B.A., M.D.

Chief Medical Officer

Ms. Karina M. Fedasz

Interim Chief Financial Officer

Mr. David Allan White C.A., C.P.A., ICD.D

Chief Executive Officer

Mr. Andrew D. Skibo Ph.D.

Global Head of Biologics Operations

Mr. Theodore Scott Yoho

Head of Business Development

FAQs

What is Onconetix share price today?

Onconetix share price today is $0.56 as on at the close of the market. Onconetix share today touched a day high of $0.58 and a low of $0.54.

What is the 52 week high and 52 week low for Onconetix share?

Onconetix share touched a 52 week high of $200.00 on and a 52 week low of $0.56 on . Onconetix stock price today i.e. is closed at $0.56,which is 99.72% down from its 52 week high and -0.54% up from its 52 week low.

What is Onconetix's market capitalisation today?

Onconetix market capitalisation is $0.00T as on .

How to invest in Onconetix Stock (ONCO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Onconetix on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Onconetix Stock (ONCO) from India?

Indian investors can start investing in Onconetix (ONCO) shares with as little as ₹95.2699966430664 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.70 in Onconetix stock (as per the Rupee-Dollar exchange rate as on ). Based on Onconetix share’s latest price of $0.56 as on October 14, 2026 at 1:29 am IST, you will get 17.9533 shares of Onconetix. Learn more about fractional shares .